Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc.

Healthcare

NASDAQ:TMCI · NASDAQ Global Select

Market Cap $262.09M Beta 1.41 P/E (TTM) -4.3
$4.06 +3.84%

+$0.15 today

52W Low $1.17High $7.78

Vol 1.00M · Avg 0.70M

EPS (TTM)-$0.95
Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-28.40%

Period High

$7.70

Period Low

$1.20

Latest

$4.06

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health
EH

Enhabit, Inc.

EHAB

$706.91M

CB

CeriBell, Inc.

NASDAQ:CBLL

$700.80M

SR

Surmodics, Inc.

SRDX

$614.51M

Bioventus Inc.

Bioventus Inc.

NASDAQ:BVS

$576.54M

The Oncology Institute, Inc.

The Oncology Institute, Inc.

NASDAQ:TOI

$530.91M

OrthoPediatrics Corp.

OrthoPediatrics Corp.

NASDAQ:KIDS

$457.71M

Evolus, Inc.

Evolus, Inc.

NASDAQ:EOLS

$443.20M

Standard BioTools Inc.

Standard BioTools Inc.

NASDAQ:LAB

$346.53M

SM

Semler Scientific, Inc.

SMLR

$310.75M

RxSight, Inc.

RxSight, Inc.

NASDAQ:RXST

$194.98M

What is the latest TMCI filing?

The latest filing shown is 4/A dated Jun 12, 2026.

How many recent filings does TMCI have?

Intrinsic Alpha currently shows 20 recent filings for TMCI.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.